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Introduction and purpose: Cancer stem cells (CSCs) present a higher capacity to evade being 
killed by cancer agents and developing chemoresistance, thus leading to failure of conventional 
anticancer therapeutics. Nanomaterials specifically designed for targeting and treating not only 
tumor cells, but also CSCs, may encompass therapeutic and diagnostic tools, thus successfully 
eradicating the tumor. 
Materials and methods: Polymeric micelles simultaneously loaded with gold nanorods 
(GNRs) and Adriamycin were prepared and used as a novel therapeutic and diagnostic weapon. 
Epithelial cell adhesion molecule (EpCAM) is an important CSC surface marker and has been 
exploited in this work as an active targeting agent. Photoacoustic imaging was applied for GNR 
individuation and tissue recognition. 
Results: The nanosystem was demonstrated to be able to elicit effective targeting of cancer 
cells and cause their killing, in particular under laser ablation. Moreover, ex vivo photoacoustic 
imaging is able to clearly identify tumor regions thanks to GNR’s contrast.
Conclusion: The nanosystem can be considered a powerful and promising theranostic weapon 
for hepatocellular carcinoma treatment.
Keywords: gold nanorods, drug delivery, photoacoustic imaging, photothermal therapy, 
EpCAM, cancer stem cells
Introduction
About 90% of therapeutic failures in cancer patients are attributed to chemoresistance. 
Conventional therapeutic strategies, such as chemo-agents killing rapidly growing can-
cer cells, may exhibit initial success, but the eventual relapse of the tumor, due to the 
greater resistance of some cells is a critical point. A certain type of cancer cells, such as 
progenitor cells/cancer stem cells (CSCs), renders the capability to this subset of cancer 
cells to evade slaughter from a variety of structural and functional chemo-agents, thus 
accounting for nearly all therapeutic failures. However, most chemotherapeutic agents 
aim to destroy rapidly dividing cancer cells other than undifferentiated CSCs. New 
types of therapeutic strategies for targeted drug delivery to cancer cells, especially to the 
CSCs, could be promising as a radical treatment for cancer. Finding the agents for CSC 
killing could be the key to eliminate these cancer-initiator/progenitor cell CSCs, thereby 
radically abolishing the tumors. Unlike the cancer cells that were rapidly dividing and 
differentiating, CSCs underwent continuous self-renewal to avoid insult and chemo-
killing. Targeting the CSCs would provide a novel therapeutic strategy, a shift away 
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from the traditional chemotherapy. To test this hypothesis, 
we first performed an in vitro study using a sphere-formation 
assay to enrich the CSCs. This sphere-formation assay was 
originally established as an in vitro culture system to enrich 
nervous stem cells1 and was used latterly to enrich CSCs.2 
In this in vitro culture system, two important growth factors 
used were the epidermal growth factor (EGF) and basic 
fibroblast growth factor (bFGF). The use of bFGF was criti-
cal to regulate the proliferative fate of unipotent and bipotent 
EGF-generated progenitor cells.3
Hepatocellular carcinoma (HCC) is the fifth most common 
cancer and the third leading cause of cancer-related deaths 
worldwide.4 HCC is often resistant to chemotherapeutic 
drugs, with only a few drugs eliciting a therapeutic effect in 
the HCC patients.5
The treatment results obtained with chemotherapeutic 
agents in advanced HCC have been disappointing. Adriamy-
cin (Adr) has been commonly used for the comprehensive 
treatment of various cancers including HCC. Adr was one of 
the first chemotherapeutic drugs used for HCC and showed 
interesting results;6 however, the chemoresistance that devel-
oped greatly hindered its efficacy, with a marginal role in the 
treatment of HCC patients. The interest on Adr is growing 
again due to the technological advance that now allows tar-
geted release of the drug. In our previous study,7 we demon-
strated that Adr can decrease the expression of epithelial cell 
adhesion molecule (EpCAM). Recent finding demonstrated 
that EpCAM, an important CSCs surface marker, is overex-
pressed in the cancer cells contributing to chemoresistance.5 
Therefore, a targeted release of Adr could be a potential 
strategy to improve its chemotherapeutic efficacy.
Gold nanorods (GNRs) have showed promising applica-
tions in imaging, therapy, and biological sensing, thanks to 
their peculiar geometry.8 Significant biomedical applications 
based on targeted heat delivery, such as killing localized 
cancer cells by hyperthermia after optical excitation, become 
possible when GNR resonance is tuned to near-infrared 
(NIR), rays to which tissues are relatively transparent. In 
addition, under nanosecond-pulsed NIR laser irradiation, 
GNRs act as perfect contrast agent for photoacoustic (PA) 
imaging, a powerful diagnostic, noninvasive technique, 
which could be used for early cancer diagnosis.9,10 Moreover, 
by employing continuous wave NIR laser tuned in the region 
of GNR plasmonic absorption, they can increase the tem-
perature of their surroundings up to several tens of degrees, 
enabling their employment for photothermal therapy (PTT) 
of cancer.11,12 Many other nanostructured materials have been 
recently developed to efficiently convert NIR light into heat, 
but GNRs display higher photothermal conversion efficien-
cies and improved biocompatibility.13,14
Recently, a simultaneous loading of lipophilic GNRs and 
curcumin into polymeric nanomicelles (GNRs-1/curc@PMs) 
made of biocompatible PLGA-b-PEG copolymer has been 
developed and used for in vivo treatment of premalignant 
esophageal adenocarcinoma.15
A similar strategy is exploited in the present work to 
create a drug delivery carrier able to host two different 
therapeutic agents, Adr and GNRs, simultaneously and to 
deliver them to the site of action, thanks to decoration with 
the EpCAM antibody on the surface of the nanosystem. 
When decorated with EpCAM antibodies, Adr/GNRs@
PMs-antiEpCAM could specifically target CSCs and enhance 
the concentration of drugs in the tumor site, thereby killing, 
especially under laser irradiation, the CSCs completely.16 
Moreover, the enhanced localization of GNRs on the tumor 
region could be efficiently detected by using the photoacoust-
ing imaging, thus allowing diagnosis and therapy by using 
a single drug.
Experimental section
All chemicals were purchased from Sigma-Aldrich Co. 
(St Louis, MO, USA) and used as received. Poly(d,l-
lactide-co-glycolide) (50/50) with carboxylic acid end group 
(PLGA-COOH, inherent viscosity 0.12 dL/g, MW ~7 kDa) 
was purchased from Lakeshore Biomaterials (Birmingham, 
AL, USA). Polyethylene glycol with amino and carboxylic 
acid end groups (NH
2
-PEG-COOH, MW ~3 kDa) was pur-
chased from Rapp Polymere GmbH (Tübingen, Germany). 
All aqueous solutions were prepared with deionized water 
obtained using an ultrafiltration system (Milli-Q; EMD 
Millipore, Billerica, MA, USA) with a measured resistivity 




 was passed through basic alumina 
prior to use. Dynamic light scattering measurements were 
performed on a Malvern Zetasizer-nano-S working with a 
532 nm laser beam. ζ potential measurements were con-
ducted in DTS1060C-Clear disposable zeta cells at 25°C. 
SpectraAA 100 Varian was used for atomic absorption 
spectroscopy analysis. Final concentration of the suspensions 
was determined by gravimetric analysis by drying 100 µL of 
solution at 120°C for 24 hours then accurately weighting the 
residual dry matter amount. Amount of Adr entrapped in the 
polymeric micelles was determined by fluorescence analysis 
with an Ediburg FLSP920 spectrofluorimeter equipped with 
a 450 W Xenon arc lamp.







In a common procedure, 40 mL of 1.25 mM solution of GNRs 
coated with cetyltrimethyl ammonium bromide, obtained 
as previously reported,17 were added dropwise to a solu-
tion composed of 140 mg of ethyl 11-(4-mercaptobenzoyl) 
undecanoate (Ligand 1) in 40 mL of warm ethanol. Ligand 
exchange reaction was allowed to take place by shaking 
overnight. Lipophilic GNRs-1 were precipitated by cen-
trifugation (10 minutes, 6 krpm) and washed twice with 
ethanol. The final pellet was then collected in 18 mL of 
dichloromethane (DCM). Successively, Adr/GNRs@PMs 
were prepared by water-in-oil-in-water (w/o/w) double 
emulsion solvent evaporation method. First, 2 mL of Adr 
1 mg mL−1 in water were emulsified by tip-probe sonica-
tion with 18 mL of GNRs-1 in DCM in which 100 mg of 
PLGA-b-PEG-COOH and 100 mg of PLGA-b-PEG-NH
2
 
have been dissolved. Then, the obtained emulsion was further 
emulsified with 80 mL of water in which 1 g of sodium 
cholate hydrate had been dissolved as stabilizer. The organic 
solvent was evaporated in vacuum and PMs were purified 
on Amicon Ultra centrifugal filters (MWCO 300 kDa) and 
finally collected in 10 mL. Afterward, 5 mL of Adr/GNRs@
PMs underwent antibody conjugation. First, 12 µg of anti-
EpCAM were added to 5 mL of a solution containing 1 mg 
of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydro-
chloride (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
[EDC]) and 1 mg of N-hydroxysulfosuccinimide sodium salt 
(sulfo-NHS). After 1 hour under stirring conditions, 5 mL of 
Adr/GNRs@PMs was added dropwise, and conjugation was 
allowed to happen by stirring overnight. Then, Adr/GNRs@
PMs-antiEpCAM (also called binary bomb-EpCAM) 
were purified on Amicon Ultra centrifugal filters (MWCO 
300 kDa) and finally collected in 4 mL of water.
Identification of binary bomb-EpCAM in 
hepa1-6 cell spheroids
Hepa1-6 cell line (CRL-1830) was purchased from American 
Type Culture Collection (Manassas, VA, USA).
For sphere formation assay, Hepa1-6 cells were seeded 
in an eight-well chamber slide at a density of 106 cells per 
well. When cells reached ~90% confluence, serum-free 
DMEM/F12 medium supplied with EGF and bFGF was 
used as the standard spheroid condition to enrich CSCs, 
which was a well-established assay.18 The cells were then 
treated with 100 µg of binary bomb-EpCAM for 12 hours. 
To identify binding of binary bomb-EpCAM to Hepa1-6 cell 
spheroids, the chamber was removed from the slide. The 
slide was washed and fixed with cold acetone (−20°C) for 2 
minutes. After fixing, the slides were washed with PBS-T, 
and blocked with 10% FBS for 30 minutes at room tempera-
ture. The slide was then exposed to 1:100 dilution of donkey 
anti-mouse IgG1-PE-conjugated antibody for 1 hour at room 
temperature. The positive PE staining was examined under a 
fluorescence microscope at 200× magnification.
cell viability
For non-spheroid assay, Hepa1-6 cells were seeded in 96-well 
plates at a density of 2×105 cells per well. Three days after 
cell seeding, the cells reached ~80% confluence and were 
followed by serum-free medium for 12 hours. For sphere 
formation assay, Hepa1-6 cells were seeded in 96-well plates 
at a density of 106 cells per well. When cells reached ~90% 
confluence, serum-free DMEM/F12 medium supplied with 
EGF and bFGF was used as a standard spheroid condition to 
enrich CSCs. Both non-spheroids and spheroids were treated 
with binary bomb-EpCAM at the concentrations of 12.5, 25, 
50, and 100 µg for 12 hours. After the treatment, cells were 
then exposed to NIR laser light at a wavelength of 808 nm 
using a diode-pumped solid-state laser (DPSSL) system. 
The power density of exposure was 1 minute at 3 W/cm2 as 
previously reported.15 Cell viability was evaluated by MTT 
reduction assay. The growth inhibition was calculated based 
on mean optical density values from triplicate wells for each 
treatment to determine cell viability. The MTT assay was 
repeated three times for each measurement.
Orthotropic tumor model
To establish a xenograft HCC model, male C57L/J mice 
(Jackson Laboratory, Bar Harbor, ME, USA) at 8 weeks 
old and a mouse hepatoma cell line, hepa1-6, were used. 
C57L/J mouse is syngeneic with BW7756 mouse, while 
the hepa1-6 cell line is a derivative of the BW7756 mouse 
hepatoma and shows a reliable tumor growth in the synge-
neic host C57L/J mouse. Laparotomy was performed, and 
hepa1-6 cells were inoculated at 106 cells into the right liver 
lobe of C57L/J mouse. The tumor growth was monitored 
weekly by resolution ultrasound (US) (Vevo 770™-120 
image system; Visualsonics Inc., Toronto, ON, Canada). 
The representative image is showed in Figure 1. Animal 
procedures were approved by the Institutional Animal Care 
and Use Committee of University of Louisville, which is 
certified by the American Association for Accreditation of 
Laboratory Animal Care.






antiepcaM) administration and NIr light 
exposure
When the tumor growth reached 1.5–2.5 mm2 by the US mea-
surement, laparotomy was performed in the animals again, 
and the animals were injected intra-tumorally with 100 µL 
Adr/GNRs@PMs-antiEpCAM at a concentration of 100 µg 
in saline or with the same amount of saline solution for the 
control group. Twelve hours later, the mice were anesthetized 
and exposed to an 808 nm light produced using a DPSSL 
system. Three days after the treatment, the animals were 
sacrificed and required tissues fixed in 10% buffered formalin 
for histological examination. Tumor tissues were also frozen 
in liquid nitrogen for immunofluorescence examination.
Identification of Adr/GNRs@PMs-
antiepcaM in hcc tissues
The frozen tissues were sectioned, and the slides were fixed in 
cold acetone (−20°C) for 2 minutes. After fixing, the slides were 
washed with PBS-T and blocked with 10% FBS for 30 minutes 
at room temperature. DAPI was used for staining at 1:1,000 as 
a counter stain for the nuclei. The slides were washed again 
and exposed to the antibody at 1:100 dilution of anti-mouse 
IgG1-fluorescein isothiocyanate (FITC)-conjugated antibody to 
identify the location of Adr/GNRs@PMs-antiEpCAM within 
the cancerous tissues. FITC-positive staining was examined 
under a fluorescence microscope at 200× magnification.
histopathology
The formalin-fixed tumor tissues were embedded in par-
affin. Serial sections of 5 mm were mounted onto glass slides 
for histopathological analysis. H&E-stained slides were 
obtained for each sample for the histological study.
Quantification of HCC cell killing by 
silver staining
The formalin-fixed tumor tissues were embedded in paraffin. 
Serial sections of 5 mm were mounted onto glass slides for 
histopathological analysis. Silver staining was obtained for 
each sample for the histological study quantification of HCC 
cell killing in cancerous tissue treatments of Adr/GNRs@
PMs-antiEpCAM and Adr/GNRs@PMs before and after 
laser exposure. The cell numbers were counted per high 
power in the digital images acquired with the Olympus 1×51 
microscope at 20× magnification using the Olympus DP72 
digital camera via the cellSens Dimension imaging system 
(Olympus Corporation, Tokyo, Japan).
Immunofluorescence examination of 
csc surface marker
The frozen tissues were sectioned, and slides were fixed in 
cold acetone (−20°C) for 2 minutes. After fixing, the slides 
were washed with PBS-T, and blocked with 10% FBS for 
30 minutes at room temperature. The slides were washed again 
and exposed to 1:200 dilution of FITC-conjugated antibodies 
(anti-EpCAM and anti-CD133) to identify the expression of 
EpCAM and CD133 within the cancerous tissue treatments of 
Adr/GNRs@PMs-antiEpCAM and Adr/GNRs@PMs before 
and after laser exposure. All digital images were acquired with 
the Olympus 1×51 microscope at 40× magnification using the 
Olympus DP72 digital camera via the cellSens Dimention 
imaging system (Olympus Corporation) and stored as JPG data 
files, with fixed resolutions of 200 pixels/inch. FITC-positive 
staining was examined under a fluorescence microscope at 
200× magnification. A computer image analysis was per-
formed to quantify the expressions of EpCAM and CD133 in 
Adr/GNRs@PMs-antiEpCAM and Adr/GNRs@PMs before 
and after laser. The acquired color images from the immuno-
histochemical staining were defined at a standard threshold 
according to the software specification. The computer program 
then quantified the threshold area represented by color images. 
CD133 and EpCAM protein expressions were defined by the 
percentages of threshold area in acquired color images.
CSC surface marker EpCAM identified 
by Western blot
Hepa1-6 cells were seeded in 100 mm plates at a density of 
2×105 cells per well. When cells reached ~90% confluence, the 
cells were treated with Adr, Adr/GNRs@PMs-antiEpCAM 
and Adr/GNRs@PMs for 12 hours. After the treatment, cells 
Figure 1 The representative image of ultrasound detected the tumor growth in liver.
Notes: arrow indicates the tumor; length, 2.2 mm; width, 1.5 mm.





were then exposed to NIR laser light at a wavelength of 808 
nm using a DPSSL system. Protein levels for EpCAM were 
semi-quantified by Western blot analysis as described previ-
ously. Electrophoresis was performed on 12% SDS-PAGE 
gel and the proteins were transferred to nitrocellulose mem-
branes. Membranes were incubated with primary antibody of 
EpCAM overnight at 4°C and with secondary antibody for 
1 hour at room temperature. The antigen–antibody complexes 
were then visualized using ECL (Amersham, Piscataway, NJ, 
USA). The protein bands were quantified by densitometry 
analysis, and the protein expression was presented in a pixel 
ratio of target protein vs endogenous reference, β-actin.
ex vivo Pa evaluation
The PA acquisitions were made by Vevo LAZR 2100 by FUJI-
FILM VisualSonics Inc. This multimodal imaging platform 
provides PA images co-registered with B-mode images of 
the surrounding structures. PA signals were excited by laser 
pulses of 6–8 ns pulse width generated at a rate of 20 Hz by a 
Nd:YAG laser with an optical parametric oscillator that makes 
it tunable in the optical window from 680 to 970 nm. The PA 
spectra of GNRs have been characterized by evaluating the 
spectral response on tissue mimicking agar phantoms, and we 
compared the PA response generated from the injection treated 
and healthy livers. The PA spectral response of healthy liver 
was calculated as an average of PA signals produced from 36 
regions of interest (ROIs, area ~0. 334 mm2), randomly placed 
on liver tissue regions acquired from two different slices. 
The PA images have been processed by spectral unmixing 
techniques19,20 by using a tool provided by the software of 
VevoLAZR 2100 imaging. The pattern of distribution of tar-
geted nanomaterials has been assessed ex vivo in two samples 
EpCAM1 and EpCAM2 (as described in the previous section). 
The PA signal from the targeted-GNRs has been recorded, 
together with the endogenous oxy/deoxy-hemoglobin distribu-
tion. We acquired the whole liver images at fixed wavelength 
(840 nm), prescribing single step of 150 µm, in order to obtain 
the 3D PA-US renders. We evaluated the total averaged PA 
signal on the whole sample of explanted livers. The PA records 
were compared with the relative inductively coupled plasma 
mass spectrometry (ICP-MS) data. In addition, to find a poten-
tial correlation between PA imaging and micro-US records in 
healthy and non-healthy liver tissues, the US-acquired slices 
have been analyzed by a texture algorithm based on the evalu-
ation of 122 statistical parameters as described.21
statistical analysis
Data were collected from repeated experiments and were 
presented as mean ± SD. ANOVA was used to determine if 
differences exist. If so, a post hoc Tukey’s test was used for 
analysis of the difference between groups using SigmaPlot 




GNRs were coated on their surface with ethyl 11-mercap-
toundecanoate 1, obtained as previously reported22 in order 
to make them lipophilic and stable in organic solvents, thus 
allowing their entrapment into the polymeric micelles. After 
incubation of GNRs coated with cetyltrimethyl ammonium 
bromide with ligand 1, lipophilic GNRs-1 were easily 
redispersed in DCM. Next, GNRs-1 were entrapped along 
with Adr into polymeric nanomicelles (PMs) using water-
in-oil-in-water (w/o/w) double emulsion solvent evapora-
tion technique: the amphiphilic PLGA-b-PEG-COOH and 
PLGA-b-PEG-NH
2
 copolymers were selected to create 
biocompatible, biodegradable, and water-soluble micelles 
able to circulate for long periods of time in the bloodstream.23 
Therefore, the organic solution composed of GNRs-1 and 
copolymers was emulsified with a small amount of water 
phase containing Adr and the so-obtained pre-micelles were 
stabilized by a second emulsification with a larger amount 
of aqueous solution containing sodium cholate hydrate as 
stabilizing agent. The resulting Adr/GNRs@PMs were par-
tially kept as negative control and partially conjugated with 
the targeting agent, antiEpCAM antibody. The conjugation 
was achieved through amide bond formation between the 
carboxylic acid on the antibody fragment and the free amine 
groups on the surface of the micelles using the classical EDC 
chemistry. The entire procedure is summarized in Scheme 1.
A complete characterization of the final micelles, before 
and after conjugation with antiEpCAM antibody, was car-
ried out and reported in Table 1. Micelles showed a suitable 
size and polydispersity index for in vivo applications and 
excellent stability even after the conjugation procedure. 
Similarly, GNRs remained unaltered during the entire process 
as demonstrated by the maintenance of λmax.
Identification of binary bomb-EpCAM in 
hepa1-6 cell spheroids
To determine if the synthesized Adr/GNRs@PMs-antiEpCAM 
can bind to HCC cell spheres, immunofluorescence staining 
was performed to identify the antiEpCAM in the micelles 
using donkey anti-mouse IgG1 PE-conjugated antibody. 
Positive staining (red spots in Figure 2) was found in the 
Adr/GNRs@PM-antiEpCAM-treated Hepa1-6 cell spheroids 
but not with Adr/GNRs@PMs-treated Hepa1-6 cell spheroids, 





thus confirming the importance of the targeting EpCAM on the 
surface of micelles to increase their binding affinity for the 
CSCs which are enriched in the Hepa1-6 cell spheroids.
cell viability
Significant cell viability reduction was found in both cells 
and spheroids treated with Adr/GNRs@PMs-antiEpCAM. 
In particular, laser exposure produces a drastic decrease in 
viability of cancer cells treated with the final nanosystems, 
thus demonstrating the advantages in terms of the binary bomb 
for releasing Adr in addition to thermal ablation properties 
derived from GNR particles (Figure 2). To determine whether 
the photothermal effect of the GNRs could affect cell viability, 
the temperature was determined in the Hepa1-6 cells with 
treatments of three GNR-based micelles (GNRs@PM, GNRs@
PMs-antiEpCAM, and Adr/GNRs@PMs-antiEpCAM). The 
temperature was significantly increased with laser exposure at 
40 and 60 seconds, compared to the 0 second laser exposure. 
The cyotoxicity of GNRs@PMs and GNRs@PM-antiEpCAM 
was also determined by MTT assay. The result indicated that 
about 10% growth inhibition of Hepa1-6 cells was induced by 
the two micelles (GNRs@PMs and GNRs@PMs-antiEpCAM) 
with laser exposure, indicating that GNR-derived thermal effect 
could also contribute to the cell death which was consistent 
with our previous report (Figure 3).16
Orthotropic tumor model
An orthotropic tumor model was established for further 
study. The animal surgery procedure was reported by our 
group previously.24 Ultrasound imaging was performed 
weekly to measure the tumor size. A representative US 
image is shown in Figure 1. The tumor size was measured 
as 2.2 mm in length and 1.5 mm in width. Then the animals 
were further treated with Adr/GNRs@PM-antiEpCAM.
Identification of Adr/GNRs@PM-
antiepcaM in hcc tissues
As described in the Experimental section, the tumor burden in 
the animals were treated with Adr/GNRs@PMs-antiEpCAM 
and laser. Three days after the treatments, the animals were 
Scheme 1 Representative procedure for the synthesis of Adr/GNRs@PMs-antiEpCAM and TEM image of the final nanosystem.
Abbreviations: eDc, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide; epcaM, epithelial cell adhesion molecule; gNr, gold nanorod; Nhs, N-hydroxysulfosuccinimide 
sodium; PM, polymeric nanomicelles; TeM, transmission electron microscopy.




size, nm, mean ± sD 110.0±0.7 117.1±1.3
PDI, mean ± sD 0.258±0.04 0.270±0.03
Zpot, mV −30.8 −27.4
[au], mM 1.2 1.1
λmax, nm 820 820
[adr], µg ml−1 62 55
[anti-epcaM], µg ml−1 – 4
Abbreviations: λmax, maximum absorption wavelength; adr, adriamycin; epcaM, 
epithelial cell adhesion molecule; gNr, gold nanorod; PDI, polydispersity index; PM, 
polymeric nanomicelles; Zpot, Zeta-potential.





sacrificed and the tumor tissues were harvested. In the frozen 
tissue, Adr/GNRs@PMs-antiEpCAM binding to the tumor 
tissue was determined using immunofluorescence stain-
ing. Positive staining (green spots in Figure 4) identified 
antiEpCAM in the micelles using anti-mouse IgG1 FITC-
conjugated antibody. This result provided evidence that Adr/
GNRs@PMs-antiEpCAM also had high binding affinity with 
tumor tissue in vivo.
histopathology
Histology showed that the inoculated HCC tumor grew and 
invaded into the hepatic parenchyma. Three days after treat-
ments, it was observed that Adr/GNRs@PMs-antiEpCAM 
treatment caused tumor cell death and lymphocyte infiltration 
as well as hemorrhage in local regions. However, Adr/GNRs@
PMs-antiEpCAM treatment with laser exposure caused exten-
sive tumor cell death, implying that most tumor cells were 
killed by the binary bomb by release of Adr in addition to 
thermal ablation properties deriving from GNRs (Figure 5).
evaluation of hcc cell killing and csc 
surface markers
To evaluate the tumor cell-killing effect in vivo, a silver 
staining assay was performed to determine the tumor cell-
killing efficacy of Adr/GNRs@PMs-antiEpCAM and Adr/
GNRs@PMs. As shown in Figure 6, both of the two micelles 
showed excellent tumor cell-killing effects after laser expo-
sure. Adr/GNRs@PMs-antiEpCAM with laser exposure 
showed a significant effect of tumor cell-killing compared 
with Adr/GNRs@PMs. To evaluate whether the binary bomb 
targeted the CSC, two CSC markers were determined in the 
tumor tissues. Both the micelles showed significant effect for 
destroying the CSC markers in the tumor tissues.
Pa results
We report the patterns and the PA images acquired on dif-
ferent slices in Figure 7A–C. The typical PA spectra show 
two peaks around 700 and 800 nm over an increasing trend 
(PA intensity was between 0.05 and 0.15 a.u.) with respect 
to the increase of the wavelengths. 3D PA-US reconstruction 
of the whole healthy liver is shown in Figure 7D.
The assessment of PA readouts in different slices of 
liver samples with tumor, injected with the functionalized 
nanoparticles, showed a different PA spectral patterns and 
intensity, compared with healthy liver tissues. As shown in 
Figure S1, the mean PA spectrum calculated on the EpCAM 
samples presented a Gaussian trend with peak around 860 nm. 
The plot also reported the mean normalized signal of GNRs 
(non-functionalized nanoparticles) found in in vitro charac-
terization. The spectral shift in corresponding phantoms (test 
object been used) could be explained by the interaction of 
the functionalized GNRs and the biological environment in 
which the nanoparticles are distributed after the injection, 
which modifies the original GNR spectrum in terms of peak 
shift and shape (wideness).
To analyze and evaluate the different contributions of 
the liver tissues, endogenous chromophores, and potential 
physiological interactions in the PA US images of the 
EpCAM liver samples, we applied a commercial unmix-
ing tool, available in the Vevo LAZR analysis software. 
As shown in Figure S2, we processed the PA images using 
three different spectra: the oxy- and deoxy- hemoglobin 
spectra and the PA spectrum of GNRs, extrapolated from 
previous in vitro tests.
By unmixing processing, we obtained a spatial distribu-
tion map of different spectral distributions that revealed the 
presence of PA signal of nanoparticles in the livers analyzed. 
Figure 8A–H reports two PA-US acquisition series of 
EpCAM1 (A–D) and EpCAM2 (E–H) liver samples in which 
the PA signal distribution (A and E) and their related result 
after spectral unmixing processing (B and F) were shown. 
The PA unmixed images (Figure 8B and F) showed the PA 
spectral contribution of deoxy-hemoglobin in blue color, the 
PA spectral contribution of oxy-hemoglobin in red color and 
Figure 2 Identification of Adr/GNRs@PM-antiEpCAM in Hepa1-6 cell spheroids.
Notes: Blue: DaPI positive staining of nuclei in the spheroid. red: positive staining of antiepcaM which were labeled adr/gNrs@PMs.
Abbreviations: adr, adriamycin; epcaM, epithelial cell adhesion molecule; gNr, gold nanorod; PM, polymeric nanomicelles.
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the PA distribution due to the nanoparticles in green color. 
The 3D PA-US renders of whole liver sample (Figure 8D and 
G) were reported so as to better clarify the PA distribution 
inside the liver lobes. Figure 8D and H show the photos of 
liver samples, where the yellow circle represents the region 
of PA and US acquisition.
Representative PA images (Figure S3A) and their 
unmixed processing (Figure S3B) of another slice of liver 
lobe of EpCAM 2 were reported in which we evaluated the 
PA spectral trend by covering the whole width of the liver 
lobe with nine ROIs placed from its upper side to its lower 
side (Figure S3C). The plots of PA signals (Figure S3C) 
Figure 4 Identification of binary bomb-EpCAM tumor tissues of mice.
Notes: Blue: DaPI-positive staining of nuclei in the spheroid. green: positive staining of antiepcaM which were labeled adr/gNrs@PMs.
Abbreviations: adr, adriamycin; epcaM, epithelial cell adhesion molecule; gNr, gold nanorod; PM, polymeric nanomicelles.
Figure 5 histology of adr/gNrs@PMs-antiepcaM treatment and adr/gNrs@PMs-antiepcaM treatment with laser exposure.
Notes: left: normal liver tissue and hcc cell inoculation; right: adr/gNrs@PMs-antiepcaM treatment only and adr/gNrs@PMs-antiepcaM treatment after laser 
exposure. Adr/GNRs@PMs-antiEpCAM with laser exposure caused significantly cell death in the tumor tissue.
Abbreviations: adr, adriamycin; epcaM, epithelial cell adhesion molecule; gNr, gold nanorod; PM, polymeric nanomicelles.
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confirmed that the nanoparticles were mainly distributed 
from the central region to the outside part of the liver lobe.
The major PA response was acquired from the EpCAM 
2 sample in which the ICP-MS analysis found a higher con-
centration of gold equal to 9.42 µg/g vs 3.12 µg/g found in 
EpCAM 1 sample (Figure S4).
We examined the whole 3D PA-US acquisitions 
(Figure 9A and B): the PA signal average on a 3D volume 
representation of EpCAM 1 and EpCAM 2 found to be 0.132 
and 0.534 au confirmed a similar trend with the ratio of the 
equivalent Au content found by ICP-MS assay.
Although the number of samples was low, we tried to 
analyze the texture of the images to find a parameter that 
could describe the pattern of tumor tissue. The texture 
analysis, already tested in our previous work, was based on 
the study of 122 parameters. In this work, we applied the 
analysis on ten different slices of healthy, EpCAM 1, and 
EpCAM 2 liver samples.
Differences between the mean values of skewness evalu-
ation (with maximum difference in the map3) of healthy 
liver sample in respect to the tumors were detected.
Discussion
An ideal chemo-drug would not be toxic to normal cells but 
able to kill the cancer cells at the local tumor site. In this 
study, the Adr/GNRs@PMs-antiEpCAM was designed to 
Figure 6 Upper: Quantification of HCC cell-killing in the tumor tissue by silver staining.
Notes: Middle and lower: Identification and quantification of cancer stem cell surface markers EpCAM and CD133 by immunofluorescence staining. Blue: DAPI-positive 
staining of nuclei in the tumor tissue. green: positive staining of epcaM and cD133. B (bomb): adr/gNrs@PMs; TB (targeting bomb): adr/gNrs@PMs-antiepcaM. 
*P,0.05, **P,0.01.
Abbreviations: adr, adriamycin; epcaM, epithelial cell adhesion molecule; gNr, gold nanorod; hcc, hepatocellular carcinoma; PM, polymeric nanomicelles.






Figure 7 (A) Pa spectrum of healthy liver tissue; (B and D) two different Pa-Us slice images acquired from healthy liver, where some rOIs (0.334 mm2) in which the 
Pa signal was calculated are shown in (B); (C) the 3D Pa-Us render of healthy liver reconstructed from 176 slices of around 150 µm, the intensity of ultrasound signal in 
grayscale and Pa records in colored bars.
Abbreviations: Pa, photoacoustic; Pas, photoacoustic signal; rOI, region of interest; Us, ultrasound.
Figure 8 Pa signal distribution (A, E), spectral unmixed algorithm processing (B, F), and 3D Pa-Us renders reconstructed by 145 slices of 150 µm thickness (C, G), and 
the photos of samples (D, H), for epcaM 1 and epcaM 2, respectively. The yellow circles were placed on the tumor regions where signal was acquired. In the Pa unmixed 
images (B, F), the spatial distribution of nanoparticles is represented in green color, deoxy-hemoglobin chromophores in blue color, and oxy-hemoglobin chromophores in 
red color; gray scalebar for ultrasound signal intensity, colored scalebar for Pa signal intensity.
Abbreviations: epcaM, epithelial cell adhesion molecule; Pa, photoacoustic; Us, ultrasound.





release the Adr drug and GNRs under the control of NIR 
light exposure.
In the literature, a number of studies describe the photo 
thermal effect generated by the light irradiation of gold 
nanoparticles in tumors.25–27 Indeed, production of plasmonic 
resonances can be stimulated and used to increase the local 
temperature drastically to provide heating capabilities to 
the nanoparticles to kill the cancer cells, without damage 
to the healthy tissue. This effect was extensively studied 
and demonstrated in different ways. In particular, Norouzi 
et al28 in 2018 reviewed the past studies of PTT using gold 
nanoparticles, underlining the efficacy of the methodology 
and how it is possible to apply PTT by manipulating the 
physical characteristics of gold nanoparticles, in terms of size, 
synthesis, and other reported parameters. The GNRs used 
in the present work, that is, Adr/GNRs@PM-antiEpCAM, 
have similar physical–chemical characteristics and optimized 
aspect ratio to those reported in literature, leading to a com-
parable heating performances vs quantum yield.
The important features of this nanosystem were biocom-
patibility and controlled release of drug on to target CSCs 
leading to their elimination. Our in vitro data indicated that 
Adr/GNRs@PMs-antiEpCAM was effective to kill the 
CSCs which were enriched by the spheroid assay. When 
administrated locally into the tumor, this Adr/GNRs@
PMs-antiEpCAM also showed a tumor-killing effect, evi-
denced by extensive cell death in the tumor. Adr/GNRs@
PMs-antiEpCAM could be more efficient to kill the CSCs 
via antiEpCAM targeting because EpCAM has been identi-
fied as a surface marker, which is associated with aggressive 
clinicopathological features and indicates poor prognosis 
in patients with HCC.29 Furthermore, the increase of local 
concentration of Adr by Adr/GNRs@PMs-antiEpCAM 
would increase the efficacy in tumor cell-killing. Unlike tra-
ditional administration of chemo-agents, the unique aspect of 
Adr/GNRs@PM-antiEpCAM could be the reduced toxicity 
to benign cells because it is targeted to the EpCAM-positive 
tumor cells, other than those EpCAM-negative hepatocytes.30 
In addition, the GNRs in Adr/GNRs@PMs-antiEpCAM 
coupled with NIR light exposure could enable thermal-based 
ablation targeted specifically at the tumor site. Evidence has 
shown that cancer cells are more vulnerable to elevated tem-
peratures (42°C–49°C) compared with healthy cells, due to 
the hypoxic environment and higher metabolic rates, which 
is supported by previous report.31,32 Taken together, our study 
shows that combination of Adr/GNRs@PMs-antiEpCAM 
with NIR exposure to treat liver cancer is technically feasible. 
Drug targeting using gold nanoparticles exhibit potential for 
use in the HCC patients who are not candidates for surgery 
and considerable study on this strategy remains to be carried 
out in the future.
Conclusion
In this work we prepared and characterized for the first 
time a binary nanostructured agent, containing both the Adr 
drug and GNRs, into a biocompatible nanocarrier further 
decorated with the targeting anti-EpCAM antibody, which 
was therefore effective in recognizing and killing CSCs.
The efficacy of the novel therapeutic agent Adr/GNRs@
PMs-antiEpCAM was demonstrated both in vitro and 
in vivo. In the in vitro study, we performed combined PTT 
and laser-triggered drug (Adr) release. Upon laser exposure, 
GNRs generate hyperthermia leading both to cell porosity 
in combination with Adr-selective release from the micelles 
Figure 9 Volumes of calculation of averaged Pa signal in (A) epcaM 2 and (B) epcaM 1 liver samples.
Abbreviations: epcaM, epithelial cell adhesion molecule; Pa, photoacoustic.





to the tumor site. This demonstrated that Adr/GNRs@PMs-
antiEpCAM had a greater degree of tumor cell cytotoxicity.
The in vivo results also demonstrated that the Adr/
GNRs@PMs-antiEpCAM preferentially bind to the HCC 
cells compared with nontarget Adr/GNRs@PMs, which lead 
to a higher cytotoxicity. After laser exposure, in vivo results 
confirmed that the possible reason for the extensive tumor 
destruction in Adr/GNRs@PMs-antiEpCAM treatment could 
be the synergistic effect of GNR thermal delivery and Adr 
cell cytotoxicity.
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Figure S1 Pa mean spectra of gNrs and that of treated liver tissue after the injection of the functionalized nanoparticles.
Abbreviations: epcaM, epithelial cell adhesion molecule; gNr, gold nanorod; Pa, photoacoustic; Pas, photoacoustic signal.
λ
Figure S2 spectra used for spectral unmixing processing.
Notes: The oxy- and deoxy-hemoglobin spectra had provided from default by Vevo software, and the Pa spectrum of nanoparticles was calculated from in vitro tests.
Abbreviations: gNr, gold nanorod; Pa, photoacoustic.
λ








Figure S3 (A) Pa-Us image of a slice of liver lobe of epcaM 2. (B) slice of liver lobe of epcaM 2 shown in image a, but processed with spectral unmixing. (C) The schematic 
of rOIs placed along 9 sections (numbered from 1 to 9) and their respective plots (also numbered from 1 to 9 and reported below) of Pa signal acquired at different heights 
from the upper side to lower side of liver lobe.
Abbreviations: epcaM, epithelial cell adhesion molecule; Pa, photoacoustic; Pas, photoacoustic signal; rOI, region of interest; Us, ultrasound.
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Figure S4 PA vs ICP-MS analysis: we calculated the PA signal ratio, as reported in the panel figure of the two analyzed samples (EpCAM 1 and EpCAM 2).
Abbreviations: epcaM, epithelial cell adhesion molecule; IcP-Ms, inductively coupled plasma mass spectrometry; Pa, photoacoustic.
